Filing Details

Accession Number:
0000899243-20-031267
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-17 16:05:08
Reporting Period:
2020-11-13
Accepted Time:
2020-11-17 16:05:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1257809 Frank Mccormick C/o Bridgebio Pharma, Inc.
421 Kipling Street
Palo Alto CA 94301
Chairman Of Oncology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-13 31,632 $42.22 1,268,836 No 4 S Direct
Common Stock Disposition 2020-11-13 58,299 $42.91 1,210,537 No 4 S Direct
Common Stock Disposition 2020-11-13 10,069 $43.57 1,200,468 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the weighted average sale price of the shares sold from $41.53 to $42.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3 and 4.
  2. Corrects ending balance which was previously overstated by 100 shares in the Reporting Person's Form 4 filings on May 21, 2020 and December 31, 2019.
  3. Represents the weighted average sale price of the shares sold from $42.53 to $43.52 per share.
  4. Represents the weighted average sale price of the shares sold from $43.53 to $43.67 per share.